Johnson & Johnson (JNJ) Stock Forecast & Price Predictions for 2023, 2024-2025 and Beyond | Litefinance (2024)

is an international giant that operates under lots of brands in the healthcare segment globally. You have almost definitely used at least one of its products. The company's stocks have been rising since 2012. And it seems they have the chance to grow even more. Let's discover analysts' predictions. What is the future of Johnson and Johnson?

Johnson & Johnson Stocks: Summary

Johnson & Johnson is a world giant in the healthcare industry. The enterprise researches, develops, produces, and sells products in three key segments: Consumer Health, Pharmaceutical, and Medical Devices. Whenever you see the following brands, remember, Johnson & Johnson is their parent company: Johnson's, Aveeno, Acuvue, Listerine, Clean & Clear, Dr. Ci:Labo, Neutrogena, OGX, Tylenol, Benadryl, Zyrtec, Sudafed, Nicorette, Stayfree, Carefree, and many more.

Also, the company offers products in therapeutic areas such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases.

The Medical Devices segment includes a wide range of products that treat conditions such as hemorrhagic and ischemic stroke; support hips, knees, trauma, spine, sports; provide advanced and general surgery solutions with a focus on breast aesthetics, ear, nose, and throat procedures, as well as cataract and laser refractive surgery.

Here is some data on JNJ's stocks (New York Stock Exchange: JNJ):

• Market cap: $434.41 billion

• Shares outstanding: 2.63 billion

• Public float: 2.63 billion

• P/E ratio: 29.14

• Payout ratio: 44.58% (based on this year's estimates)

• EPS: $2.32

• Dividend Yield: 2.57%

• Total return price range (5 years): 98.49 - 170.55

• Annual dividend: $4.24

• Forecast 12-month forward PEG Ratio: 2.65

• Average volume: 7.80 million shares

The enterprise was established in 1886 but only became a publicly traded company on September 24, 1944.

The current JNJ stock quote is 159.36 US dollars.

Key Factors That Affect Johnson & Johnson Stock Price in 2023 & Beyond

There are common factors that impact stock performance, including earnings reports, internal company events, industry news, and global market conditions. We will consider what could affect the Johnson and Johnson stock forecast precisely.

Vaccine

Johnson & Johnson has been increasing its number of collaborations with different companies to develop a vaccine. Although the enterprise went through difficulties in the manufacturing and shipping of the vaccine, it's still among the leading producers. For instance, in April 2021, the FDA advised a halt in the usage of the J&J Covid vaccine after 6 female recipients experienced blood clots, and 1 died. Although stocks declined by 3% during intraday trading, the price started rising fast. This confirms that the position of vaccine producer is stronger than any challenges. Thus, the stock price is expected to keep rising.

Lawsuits

The case about talcum powder that causes cancer began in 2018 but has been still affecting the company. Shares are dramatically affected by news regarding such cases. As the firm owns various subsidiaries, it's almost impossible to avoid such cases in the future.

Right Strategy

The company bets on innovation and persistently spends funds on research and development. Around a quarter of J&J's annual sales is generated by products launched in the previous 5 years.

Also, Johnson & Johnson is a parent company of many popular brands. Thus, wise investments continue boosting the company's revenue and attracting new investors.

Revenue

The quarterly revenue constantly beats the market's expectations. It's a vital factor that triggers a stock rise even in challenging times. There is no reason to expect a decline in the company's growth.

JNJ Stock Price Forecast for 2021: Analysts’ Recommendations

Will Johnson & Johnson stock go up in 2021? The average 12-month forecast by 12 Wall Street analysts is $185.70. The maximum price target is $200.00; the lowest potential rate is $164.00. The consensus rating is "Buy" as 10 of 12 analysts set a buying rating, while 2 announced a holding rating.

Credit Suisse

Analysts at Credit Suisse raised the price target from $178 to $187 maintaining a "Strong Buy" rating.

Morgan Stanley

Morgan Stanley’ price expectation is $187. Analysts kept the "Overweight" rating.

JPMorgan Chase & Co

Analysts at JPMorgan Chase & Co predict JNJ price at $175 (the previous projected price was $157). The rating is “Neutral”.

Raymond James

Raymond James boosted the possible rate from $158 to $183. The rating is “Outperform”.

Wells Fargo & Company

Wells Fargo & Company reported a new price target for Johnson and Johnson stocks at $190 vs. $175, changing the rating from “Positive” to “Overweight”.

Johnson & Johnson Stock Technical Analysis

Let's go over the biggest time frame of the Johnson & Johnson price chart to find out the main market trends.

A stable bullish trend has manifested itself on's monthly prediction chart since 2009, developing even faster since July 2012. At the same time, trading activity has been growing gradually, confirming bulls' strength and the huge potential of the current Johnson & Johnson trend.

We can single out three main phases of the bullish trend:

• The grey area indicates the trend's bottom;

• The red and green areas indicate consolidation ranges;

• The blue area is the zone of peak values.

As we can see, the Johnson & Johnson value is located in the zone of peak values, testing the next zone. Thus, the trend's potential is high, and Johnson & Johnson projected growth might continue.

To make Johnson & Johnson stock predictions based on the technical analysis of JNJ shares, we'll lay the Fibonacci grid over the Johnson & Johnson prediction chart. The trend is currently accelerating and is far from finishing that process. So, we'll lay another grid over the current one to update the trend development phases based on the trend acceleration.

Now we can see a broad accumulation area — number 2 in the chart above. The JNJ market price is currently located there.

The upper limit of the red zone is powerful resistance confirmed by the price chart's drastic pullbacks in November 2017, December 2018, and February 2020.

The lower limit of the red zone is a strong key level, too. Let's move to the Johnson & Johnson analysis of smaller time frames to predict if that zone will be an irresistible obstacle to an eventual correction.

Johnson & Johnson Stock Forecast For Next Three Months

We will continue making our Johnson & Johnson stock forecast on the daily to identify current signals.

Let's start with indicator analysis.

There's a bullish divergence between theMACD 's chart and the Johnson & Johnson price chart marked as blue lines. That signal points to the ongoing correction's weakness and the current trend's eventual further development. There's also a narrow range marked in pink on the grid between fibs 0.618 and 0.786 within the broad consolidation area. The lower limit of that zone often serves as a support/resistance level. A pullback from that level is a current confirming bullish signal.

A further bullish movement is the likeliest scenario based on the signals above.

The Johnson & Johnson projected growth might end around 180 US dollars, the limit of the blue area of peak values.

Upon reaching that level, the JNJ price will likely drop and try to reach the lower limit of the red consolidation area.

Long-Term Johnson & Johnson shares Analysis and Forecast for 2022

To make a realistic long term Johnson & Johnson Outlook, we need to go over Johnson & Johnson price history, identify recurrent patterns, and project the Johnson & Johnson future value.

The chart above displays projected stock price for the next 12 months (orange areas). Those projections were based on Bollinger Bands readings in various trend development phases.

Johnson & Johnson rate will likely grow to 180 USD in the nearest 3-4 months.

Then, Johnson & Johnson's bearish movement will take over, and the price will slowly correct.

According to the forecast, the price chart will hold for a while to the lower limit of 0.618 fibo area, at around 165 USD. Then, the correction might continue to the lower consolidation area at 145 USD.

I'd like to emphasize that we risk having the same fractal as in March 2020 and a momentum price movement below 140 USD.

The table below presents the expected Johnson & Johnson trading range for each month in 2021-2022.

Monthly JNJ to USD price forecast

#JNJ shares Long-Term Trading Plan

Based on the forecast above, let's make a trading plan for next year.

The support level at 0.618 Fibonacci currently prevents the price from moving downwards. The price may be expected to grow slightly to the all-time maximum in the next three months. Short trades can be opened closer to 180 USD — the blue line in the chart above. Stop Loss should be placed beyond the red line, at around 160 USD. According to the likeliest scenario, Take Profit should be set at around 150 USD, the lower limit of the red consolidation area.

Remember to observe risk management rules. As the bullish trend continues, the trade is highly risky. To risk less, I suggest waiting for a correction to 150 USD and then going long.

Take care of yourself and your money!

JNJ technical analysis is presented by Mikhail Hypov.

Johnson and Johnson Stock Forecast for 2022

What should we expect next year? Wallet Investor has an optimistic JNJ stock forecast for the JNJ price in 2022. Although the price won't skyrocket, a solid bullish trend is what long-term investors need. The opening rate in January is expected to be $172.401; by the end of the year, the price will move to $181.825. Shares of huge companies such as Johnson & Johnson are stable. It's confirmed by a narrow difference between the minimum and maximum prices, around $1.5.

Source: Wallet Investor

JNJ Stock Forecast for 2023

What is the future price of JNJ shares? The bull case will continue in 2023, according to Wallet Investor. The stocks will start the year at $181.839, rising to $191.299 in December. The price won't suffer dramatic fluctuations, moving within a narrow range of USD 0.5 - 2.6.

Source: Wallet Investor

Long-Term JNJ Stock Forecast for 2025 and Beyond

Wallet Investor doesn't change its rosy Johnson and Johnson stock outlook on the JNJ price. The shares will be quoted at $200.927 in January 2025, climbing to $215.610 by July 2026. It's also important that long-term declines aren't anticipated. Although the price may go up and down, it won't result in an overall bearish trend.

Source: Wallet Investor

How much will JNJ stock be worth in 10 years? The source doesn't provide a longer-term Johnson and Johnson stock prediction as such long forecasts are subject to constant changes. The stock market is highly volatile; that's why all long-term price projections should be viewed skeptically.

A Price Timeline: JNJ Outlook

Price history is a vital part of both short- and long-term prediction. Historical stock’s moves give clues on the upcoming price direction. Even last month’s fluctuations can predict a future price.

If you look at the chart of JNJ stocks, you will see that the overall uptrend began in 2012. Since then, the price has been climbing. The price managed to set a new all-time high on May 20, 2021 when it peaked at 171.07 US dollars. If analysts' Johnson and Johnson share price forecasts are correct, the bullish trend will continue, and the price will set new highs soon.

We will have a look at the price movements since 2018. The first half of the year was negative for JNJ shares. Why was down? As Johnson & Johnson is a consumer staples company, the overall market trend pulled its stocks down. In 2018, changing consumer tastes lowered the company’s stable income, while rising interest rates made high dividend payouts less attractive.

However, the most harmful effect was caused by allegations that J&J's baby talcum powder caused cancer. The stocks plunged after the court claimed $4.7 billion payments to those who said that the company's baby powder was the cause of their cancer.

Still, the price recovered soon after the company confirmed its decision to appeal the court adjudication. Additionally, the company reported strong second-quarter revenue.

In 2019, the price moved mostly sideways. That year, the litigation over opioids and baby powder were key price drivers. J&J faced personal injury claims by more than 100,000 plaintiffs. However, better-than-expected earnings reports and growth in pharmaceutical sales supported investor sentiment.

In summer, stocks suffered as a court accused the company of intentionally playing down the dangers and oversold the benefits of opioids. In August, in the first trial for the destruction caused by prescription painkillers, the court ordered Johnson & Johnson to pay the state $572 million. In October, the price started recovering.

It's not a secret why JNJ stocks plunged in February-March 2020. The Covid pandemic affected the whole stock market. However, the shares rapidly recovered. The company started working on its own Covid-19 vaccine.

In February, the firm launched a clinical study in cooperation with Apple to define whether the Heartline™ Study app on iPhone, and the ECG app and irregular rhythm notification on Apple Watch could reduce the probability of stroke and raise health outcomes with earlier detection of atrial fibrillation.

In the past year, the company had to remove its baby powder brand in the US and Canada due to "changes in consumer habits" and "misinformation around the product's safety." In November, the company failed to reverse a $2 billion verdict related to asbestos in its baby and other talc products. However, the company's cash balance and investments helped it stay afloat even in such a difficult year.

In 2021, stocks continued rising. Although Johnson and Johnson had to temporarily halt shipping of the coronavirus vaccine in March due to the spoiling of 15 million doses, it didn't affect the share price.

Is Investing in Johnson & Johnson a Good Idea?

Johnson & Johnson is a well-known brand that operates worldwide. The company is on the list of Dividend Kings, 24 companies that have boosted their dividends for over 50 consecutive years.

Source: AI Pickup LLC

Are JNJ stocks a good buy? JNJ stocks are good for long-term investments. Additionally, you can try stock trading. A LiteFinance demo account provides a wide range of trading instruments and technical indicators to gain experience.

Price chart of JNJ in real time mode

The content of this article reflects the author’s opinion and does not necessarily reflect the official position of LiteFinance. The material published on this page is provided for informational purposes only and should not be considered as the provision of investment advice for the purposes of Directive 2004/39/EC.